Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Lymphoma, B-Cell, Marginal Zone × Prednisone × Clear all

Phase

Status

Sponsor Class

OTHER 10 NIH 6 INDUSTRY 4 NETWORK 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 2 Prostatic Neoplasms 1 Multiple Myeloma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, B-Cell, Marginal Zone 1 Congenital Abnormalities 1

Interventions

Rituximab 1 Prednisone 1 Epirubicin 1 Cyclophosphamide 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04433156 2023-05-18

VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma

Henan Cancer Hospital

Phase 2 Unknown

Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon ⚡